Alvine Pharmaceuticals

Alvine Pharmaceuticals, founded in 2006, was a clinical-stage company developing biologics to target autoimmune and inflammatory diseases. Alvine’s non-cash assets were acquired by ImmunogenX™, a subsidiary of Immunogenics LLC, in 2016.